Abstract
We have observed discreet subgroups of male patients with psychotic disorders who have unirhinal olfactory identification deficits (microsmia). The purpose of this study was to examine the relationship between left or right nostril microsmia and performance on literalised neuropsychological tests sensitive to lesions in brain areas implicated in the pathogenesis of schizophrenia. Sixty-six male patients diagnosed with schizophrenia or related disorders were assessed with a battery of neuropsychological tests, sensitive to literalised and regional (temporal and frontal lobe) dysfunction. The University of Pennsylvania Smell Identification Test (UPSIT) was administered unirhinally and resultant scores were used to classify patients into olfactory subgroups. Neuropsychological test scores were compared amongst subgroups. A mixed design MANOVA was performed on cognitive domains with olfactory status (right microsmic; RM, n=8, left microsmic; LM, n=20, and normosmic schizophrenic controls; NSzC, n=38) as the between subject factor while hemisphere (left versus right) and domain (executive/fluency versus memory) were within-subject factors. A three-way (olfactory subgroup by hemisphere by region) interaction was observed. Non-verbal memory impairment was observed in the right and left microsmic subgroups. Verbal memory deficits were demonstrated in patients with left nostril microsmia. These results indicate that unirhinal olfactory performance may provide a meaningful manner by which to subtype patients with schizophrenia. Moreover, the data suggest that olfactory deficits in patients with schizophrenia are associated with dysfunction of temporal lobe, rather than frontal lobe abnormalities. The data are consistent with reports linking the right temporal lobe integrity to adequate olfactory processing.
Original language | English |
---|---|
Pages (from-to) | 211-223 |
Number of pages | 13 |
Journal | Schizophrenia Research |
Volume | 56 |
Issue number | 3 |
DOIs | |
Publication status | Published - Aug 1 2002 |
Bibliographical note
Funding Information:This research was made possible by grants from the Medical Research Council of Canada (grant number MT-12857), the Canadian Psychiatric Research Foundation, and The Queen Elizabeth II Health Sciences Centre Research Fund. Infrastructure support was obtained from the Department of Health of the Province of Nova Scotia. Dr Good was granted a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression. Dr Honer holds a CIHR Scientist Award. We extend our thanks to Drs W. MacEwan, K. Singh, and C. Hault for access to their patients. Drs T. Hurwitz, H. Tuokko, and H.C. Fibiger provided valuable input to this study. This study partially fulfilled requirements toward a doctoral degree for Dr Good.
ASJC Scopus Subject Areas
- Psychiatry and Mental health
- Biological Psychiatry